Fabienne Lesueur

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Journal: Journal of medical genetics
Published: January 13, 2026

Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status.

Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status.

Journal: NPJ digital medicine
Published: September 22, 2025

Cancer risks for ATM variant heterozygotes.

Cancer risks for ATM variant heterozygotes.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 01, 2025

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: July 09, 2025

Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.

Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.

Journal: Thyroid : official journal of the American Thyroid Association
Published: March 26, 2025

Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.

Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.

Journal: Cancers
Published: February 03, 2025

Body Mass Index, IGF1-Related Polymorphisms, and Risk of Familial Breast Cancer in Women with No BRCA1 or BRCA2 Pathogenic Variant.

Body Mass Index, IGF1-Related Polymorphisms, and Risk of Familial Breast Cancer in Women with No BRCA1 or BRCA2 Pathogenic Variant.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 06, 2025

Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Journal: Breast cancer research : BCR
Published: November 18, 2024

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Journal: medRxiv : the preprint server for health sciences
Published: March 18, 2024

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Journal: NPJ genomic medicine
Published: March 14, 2024

Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.

Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.

Journal: Cancers
Published: March 05, 2024

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

Journal: Journal of medical genetics
Published: February 21, 2024
Showing 1-12 of 130

Last Updated: 09/26/2026